Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-25-002136
Filing Date
2025-08-08
Accepted
2025-08-08 16:05:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8991
2 ex991to13g09729imux_080825.htm EX-99.1 5195
  Complete submission text file 0000921895-25-002136.txt   15993
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88651 | Film No.: 251198364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019
Business Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

EIN.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G